Skip to main content
Fig. 1 | BMC Medicine

Fig. 1

From: Development of prescribing indicators related to opioid-related harm in patients with chronic pain in primary care—a modified e-Delphi study

Fig. 1

The process of developing opioid prescribing indicators. Note: This flowchart illustrates the ongoing development process, and this article presents the results for stages a, b and c. The study outcomes are summarised in Table 3, Table 4, and Additional File 8. *Semi-structured interviews with patients and healthcare professionals were conducted and identified the perceived usability of opioid prescribing indicators (Neetu Bansal, Chiu-Yi Lin, Li-Chia Chen. Patients and healthcare professionals’ perspectives on using opioids for managing chronic pain in primary care — a qualitative study in the Greater Manchester area. Poster presentation. Poster presentation. Prescribing and Research in Medicines Management (PRIMM) (UK & Ireland) conference 2022. Pharmacoepidemiology and Drug Safety, 2022. Pharmacoepidemiology and Drug Safety 2022 Vol. 31 Issue S1 Pages 14–15. DOI: https://0-doi-org.brum.beds.ac.uk/10.1002/pds.5499)

Back to article page

BMC Medicine

ISSN: 1741-7015

Contact us